CLINICAL_TRIALS
trial_result
· 2017-02-10
Clinical Trial Update: A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes [Phase 1]
Summary
A Phase 1 trial evaluating the exposure of NN5401 in young adults and elderly subjects with Type 1 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED